Literature DB >> 17962438

Clinical light exposure, photoreceptor degeneration, and AP-1 activation: a cell death or cell survival signal in the rhodopsin mutant retina?

Danian Gu1, William A Beltran, Zexiao Li, Gregory M Acland, Gustavo D Aguirre.   

Abstract

PURPOSE: The T4R RHO mutant dog retina shows retinal degeneration with exposures to light comparable to those used in clinical eye examinations of patients. To define the molecular mechanisms of the degeneration, AP-1 DNA-binding activity, composition, posttranslational modification of the protein complex, and modulation of ERK/MAPK signaling pathways were examined in light-exposed mutant retinas.
METHODS: Dark-adapted retinas were exposed to short-duration light flashes from a retinal camera used clinically for retinal photography and were collected at different time points after exposure. Electrophoretic mobility shift assay (EMSA), supershift EMSA, Western blot analysis, and immunocytochemistry were used to examine AP-1 signaling.
RESULTS: Exposure to light of mutant retinas significantly increased AP-1 DNA-binding activity by 1 hour after exposure, and levels remained elevated for 6 hours. Shielded mutant retinas had similar AP-1 levels to shielded or exposed wild-type retinas. The parallel phosphorylation of c-Fos and activation of ERK1/2 was detected only in exposed mutant retinas. Exposure to light changed the composition of the AP-1 protein complex in the mutant retina from c-Jun/Fra-1/c-Fos to JunB/c-Fos. Immunohistochemistry showed that the components of activated AP-1 (JunB, and phosphorylated c-Fos, and phosphorylated ERK1/2 isoforms) were localized in Müller cells.
CONCLUSIONS: The inner nuclear layer/Müller cell localization of the key proteins induced by light exposure raises the question of the direct involvement of AP-1 in mediating photoreceptor cell death in this model of autosomal dominant retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962438      PMCID: PMC2377016          DOI: 10.1167/iovs.07-0428

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

Review 1.  Histopathology of the human retina in retinitis pigmentosa.

Authors:  A H Milam; Z Y Li; R N Fariss
Journal:  Prog Retin Eye Res       Date:  1998-04       Impact factor: 21.198

Review 2.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 3.  Role and regulation of activator protein-1 in toxicant-induced responses of the lung.

Authors:  Sekhar P M Reddy; Brooke T Mossman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-12       Impact factor: 5.464

4.  Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa.

Authors:  James W Kijas; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Susan E Pearce-Kelling; Brian J Miller; Samuel G Jacobson; Gustavo D Aguirre; Gregory M Acland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.

Authors:  Eliot L Berson; Bernard Rosner; Carol Weigel-DiFranco; Thaddeus P Dryja; Michael A Sandberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

6.  Histopathologic study of variation in severity of retinitis pigmentosa due to the dominant rhodopsin mutation Pro23His.

Authors:  King To; Michael Adamian; Thaddeus P Dryja; Eliot L Berson
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

7.  A naturally occurring mutation of the opsin gene (T4R) in dogs affects glycosylation and stability of the G protein-coupled receptor.

Authors:  Li Zhu; Geeng-Fu Jang; Beata Jastrzebska; Slawomir Filipek; Susan E Pearce-Kelling; Gustavo D Aguirre; Ronald E Stenkamp; Gregory M Acland; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

8.  Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect.

Authors:  G D Aguirre; V Baldwin; S Pearce-Kelling; K Narfström; K Ray; G M Acland
Journal:  Mol Vis       Date:  1998-10-30       Impact factor: 2.367

9.  Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man.

Authors:  A V Cideciyan; D C Hood; Y Huang; E Banin; Z Y Li; E M Stone; A H Milam; S G Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Evidence for two apoptotic pathways in light-induced retinal degeneration.

Authors:  Wenshan Hao; Andreas Wenzel; Martin S Obin; Ching-Kang Chen; Elliott Brill; Nataliia V Krasnoperova; Pamela Eversole-Cire; Yelena Kleyner; Allen Taylor; Melvin I Simon; Christian Grimm; Charlotte E Remé; Janis Lem
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

View more
  13 in total

1.  Effect of brain-derived neurotrophic factor on c-jun expression in the rd mouse retina.

Authors:  Rui Chen; Xiao-Bei Yin; Chun-Xia Peng; Gen-Lin Li
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 2.  Genetic and phenotypic variations of inherited retinal diseases in dogs: the power of within- and across-breed studies.

Authors:  Keiko Miyadera; Gregory M Acland; Gustavo D Aguirre
Journal:  Mamm Genome       Date:  2011-11-08       Impact factor: 2.957

3.  Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.

Authors:  Simone Iwabe; Gui-Shuang Ying; Gustavo D Aguirre; William A Beltran
Journal:  Exp Eye Res       Date:  2016-04-13       Impact factor: 3.467

4.  Mutations of the opsin gene (Y102H and I307N) lead to light-induced degeneration of photoreceptors and constitutive activation of phototransduction in mice.

Authors:  Ewa Budzynski; Alecia K Gross; Suzanne D McAlear; Neal S Peachey; Meera Shukla; Feng He; Malia Edwards; Jungyeon Won; Wanda L Hicks; Theodore G Wensel; Jurgen K Naggert; Patsy M Nishina
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.

Authors:  Artur V Cideciyan; Raghavi Sudharsan; Valérie L Dufour; Michael T Massengill; Simone Iwabe; Malgorzata Swider; Brianna Lisi; Alexander Sumaroka; Luis Felipe Marinho; Tatyana Appelbaum; Brian Rossmiller; William W Hauswirth; Samuel G Jacobson; Alfred S Lewin; Gustavo D Aguirre; William A Beltran
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

6.  Steroids do not prevent photoreceptor degeneration in the light-exposed T4R rhodopsin mutant dog retina irrespective of AP-1 inhibition.

Authors:  Danian Gu; William A Beltran; Sue Pearce-Kelling; Zexiao Li; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

7.  AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.

Authors:  Ji-Jing Pang; Sanford L Boye; Ashok Kumar; Astra Dinculescu; Wentao Deng; Jie Li; Qiuhong Li; Asha Rani; Thomas C Foster; Bo Chang; Norman L Hawes; Jeffrey H Boatright; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

8.  The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells.

Authors:  Monica L Gavala; Zachary A Pfeiffer; Paul J Bertics
Journal:  J Leukoc Biol       Date:  2008-07-14       Impact factor: 4.962

Review 9.  Gene augmentation for adRP mutations in RHO.

Authors:  Alfred S Lewin; Brian Rossmiller; Haoyu Mao
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

10.  Exclusion of the unfolded protein response in light-induced retinal degeneration in the canine T4R RHO model of autosomal dominant retinitis pigmentosa.

Authors:  Stefania Marsili; Sem Genini; Raghavi Sudharsan; Jeremy Gingrich; Gustavo D Aguirre; William A Beltran
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.